Rising Costs: Drug Pricing Debates in 2019

As Democrats settle into their majority in the House and Republicans boast a wider majority in the Senate, many pundits foresee legislative gridlock in the coming months. While the parties remain deeply split on certain issues, leaders on both sides have identified high prescription drug prices as an area of potential bipartisan agreement.
Join us for a webinar on March 21 to explore what this could mean in coming months. We'll discuss:
  • Drug pricing legislation so far and related initiatives in the 116th Congress
  • Potential future legislation and other factors that could impact drug pricing
  • Where Democrats and Republicans agree on drug pricing and where their proposals and efforts diverge

Register to join a panel of National Journal Presentation Center analysts for this in-depth discussion and a look ahead at prescription drug pricing in the U.S. in 2019.